Kiem Lab's Korashon Watts explores cord blood stem cell expansion; lauded by American Society of Gene & Cell Therapy
May 21, 2012
| By Colleen Steelquist
Dr. Korashon Watts of the Fred Hutchinson Cancer Research Center Clinical Research Division recently won an Excellence in Research award from the American Society of Gene & Cell Therapy. Her abstract, focused on cord blood stem cell expansion, was selected as one of the top six submitted by a postdoctoral fellow or student for the ASGCT annual meeting in Philadelphia earlier this month.
Hans-Peter Kiem study is first to show patients' own gene-modified blood stem cells can protect bone marrow from chemotherapy toxicity
May 14, 2012
| By Dean Forbes
For the first time, Fred Hutchinson Cancer Research Center scientists have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. Initial results of the ongoing, small clinical trial of three patients with glioblastoma showed that two patients survived longer than predicted if they had not been given the transplants, and a third patient remains alive with no disease progression almost three years after treatment.